Website review volv.swiss
Generated on December 08 2025 14:08 PM
Old data? UPDATE !
The score is 54/100
SEO Content
Title
Volv Global | Towards better healthcare
Length : 39
Perfect, your title contains between 10 and 70 characters.
Description
Volv Global personalises healthcare by providing insights on patients and diseases powered by data-driven AI and machine learning.
Length : 130
Great, your meta description contains between 70 and 160 characters.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| locale | en_GB |
| type | website |
| title | Volv Global | Towards better healthcare |
| description | Volv Global personalises healthcare by providing insights on patients and diseases powered by data-driven AI and machine learning. |
| url | https://volv.global/ |
| site_name | Template |
| updated_time | 2025-11-11T22:19:39+01:00 |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 13 | 57 | 0 | 0 | 0 |
- [H1] Where technology meets Human
- [H2] Shaping the future today for a better tomorrow
- [H2] Volv Global’s suite of services
- [H2] Improving lives with better tools and treatments
- [H2] Insights & Events
- [H2] Insights & Events
- [H2] Case studies
- [H2] How we help you
- [H2] inTrigue
- [H2] What we do
- [H2] Insights
- [H2] Meet Volv Global
- [H2] inTrigue
- [H2] Meet Volv Global
- [H3] Personalise the patient journey
- [H3] Target patient populations
- [H3] Expand medical knowledge
- [H3] Healthcareefficiencies
- [H3] Adding value through unprecedented insights
- [H3] Impact across the product lifecycle
- [H3] Clinical Development
- [H3] Value and Access, HEOR
- [H3] Medical Affairs
- [H3] Commercial Excellence
- [H3] AI Powered Solutions for Rare Disease and Healthcare Innovation
- [H3] Advanced, proprietary machine learning technology for patient-disease insights
- [H3] We find more patients
- [H3] We detect diseases at an earlier stage
- [H3] We predict patient outcomes
- [H3] We stratify patient cohorts
- [H3] MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification
- [H3] Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat
- [H3] Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification
- [H3] PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation
- [H3] Beyond the Hype: Volv Global CEO Christopher Rudolf at Frontiers Health 2025
- [H3] Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs
- [H3] MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification
- [H3] Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat
- [H3] Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification
- [H3] PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation
- [H3] Beyond the Hype: Volv Global CEO Christopher Rudolf at Frontiers Health 2025
- [H3] Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs
- [H3] Where Technology Meets Human: A Call to Unite Clinical Expertise and Real‑World Patient Voices
- [H3] Unlocking the Future of Type 1 Diabetes Care: Why Earlier Diagnosis Must Match Innovation in Treatment
- [H3] News Article: AI in healthcare
- [H3] Webinar: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: a case study
- [H3] World Orphan Drug Congress Europe 2025 | Volv Global in Amsterdam
- [H3] Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI: Volv Global at the Rare Trials Summit 2025
- [H3] Beyond Quick Fixes: How Predictive Modelling Can Redefine Clinical Trial Enrolment
- [H3] Beyond Initial Treatment: Navigating Recurrence Risk and Clinical Decisions in Cancer Survivors
- [H3] Unlocking the Full Impact of Breakthrough Therapies in Breast Cancer Through Earlier Detection
- [H3] Progressive Pulmonary Fibrosis: Solving the Puzzle of Poor Disease Control
- [H3] Conference Posters: ATS 2025, 17-21 May
- [H3] Conference Poster: Swiss Biotech Day 2025, 5th-6th May
- [H3] Unlocking the Power of EMR Data for Earlier Gastric Cancer Diagnosis and Risk Prediction
- [H3] Press Release: Volv Global Expands Office Footprint to Power Next-Generation AI Innovation in Healthcare
- [H3] A Rare Disease Day Message from Dr. Al Freedman
- [H3] Where technology meets Human: Volv Global at the World Orphan Drug Congress USA 2025
- [H3] News Article: Volv Global Tracks Nearly Undetectable Diseases
- [H3] White Paper: The Path to Rare Disease Clinical Trial Innovation
- [H3] Webinar: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: a case study
- [H3] Poster: Alpha-1 Antitrypsin Deficiency: Why millions remain undiagnosed
- [H3] Finding Patients for Rare Diseases: A Case Study
- [H3] Webinar: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: a case study
- [H3] Poster: Alpha-1 Antitrypsin Deficiency: Why millions remain undiagnosed
- [H3] Finding Patients for Rare Diseases: A Case Study
- [H3] Case Study: Detecting signs of Fabry and Pompe disease in UK clinical data
- [H3] Webinar: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: a case study
- [H3] Poster: Alpha-1 Antitrypsin Deficiency: Why millions remain undiagnosed
- [H3] Finding Patients for Rare Diseases: A Case Study
- [H3] Case Study: Detecting signs of Fabry and Pompe disease in UK clinical data
Images
We found 14 images on this web page.
4 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.
Text/HTML Ratio
Ratio : 0%
This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
Perfect! No underscores detected in your URLs.
In-page links
We found a total of 34 links including 0 link(s) to files
SEO Keywords
Keywords Cloud
intrigue access patient global consent preferences manage title meet insights
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| patient | 6 |  |
|
 |
|
| manage | 5 | |
|
|
|
| insights | 4 | |
|
|
|
| access | 3 | |
|
|
|
| consent | 3 | |
|
|
|
Usability
Url
Domain : volv.swiss
Length : 10
Favicon
Very bad. We have not found shortcut icon. Icons are one of easy ways to attract regular visitors to your website more often.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Great, your website has few CSS files. |
|
Too bad, your website has too many JS files (more than 6). |
|
Perfect, your website takes advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Great, your website has an XML sitemap.
| https://volv.global/sitemap_index.xml |
Robots.txt
http://volv.swiss/robots.txt
Great, your website has a robots.txt file.
Analytics
Great, your website has an analytics tool.
Google Analytics |
PageSpeed Insights
Device
Categories
Website-SEO-Überprüfung
Website-SEO-Überprüfung is a free SEO tool which provides you content analysis of the website.